Dr. Aura-Marie Pawley, M.D

NPI: 1639207400
Total Payments
$6,832
2024 Payments
$1,301
Companies
27
Transactions
355
Medicare Patients
182
Medicare Billing
$67,189

Payment Breakdown by Category

Food & Beverage$6,777 (99.2%)
Education$54.54 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,777 354 99.2%
Education $54.54 1 0.8%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $1,020 51 $0 (2024)
Lundbeck LLC $880.97 49 $0 (2024)
Allergan, Inc. $784.10 46 $0 (2020)
Sunovion Pharmaceuticals Inc. $519.59 28 $0 (2018)
Takeda Pharmaceuticals U.S.A., Inc. $507.77 27 $0 (2024)
Alkermes, Inc. $451.73 20 $0 (2024)
Teva Pharmaceuticals USA, Inc. $322.04 19 $0 (2024)
Tris Pharma Inc $291.61 20 $0 (2024)
Janssen Pharmaceuticals, Inc $224.26 9 $0 (2024)
Vanda Pharmaceuticals Inc. $169.23 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,301 59 Takeda Pharmaceuticals U.S.A., Inc. ($143.94)
2023 $499.90 24 Takeda Pharmaceuticals U.S.A., Inc. ($68.42)
2020 $342.46 17 Otsuka America Pharmaceutical, Inc. ($69.34)
2019 $1,344 72 Allergan Inc. ($226.54)
2018 $1,700 92 Otsuka America Pharmaceutical, Inc. ($433.08)
2017 $1,644 91 Lundbeck LLC ($304.58)

All Payment Transactions

355 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/23/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $22.73 General
Category: PSYCHIATRY
12/19/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $13.97 General
Category: Psychiatry/Psychology
12/17/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $24.91 General
Category: CNS Stimulant for ADHD
12/11/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $32.60 General
Category: Psychology/Psychiatric
12/03/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.10 General
Category: NEUROSCIENCE
11/21/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $14.66 General
Category: Psychology/Psychiatric
11/19/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Education In-kind items and services $54.54 General
Category: Psychiatry/Psychology
11/19/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $25.66 General
Category: Psychiatry/Psychology
11/12/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $8.45 General
Category: NEUROSCIENCE
11/05/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $18.44 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
10/29/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $15.87 General
Category: PSYCHIATRY
10/22/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $20.86 General
Category: Central Nervous System
10/18/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.60 General
Category: NEUROSCIENCE
10/15/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $20.85 General
Category: PSYCHIATRY
10/10/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $10.93 General
Category: NEUROSCIENCE
10/08/2024 Tris Pharma Inc Dyanavel XR (Drug) Food and Beverage In-kind items and services $14.34 General
Category: ADHD
10/01/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $24.80 General
Category: PSYCHIATRY
09/26/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $22.47 General
Category: Neurology
09/24/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.06 General
Category: NEUROSCIENCE
09/17/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $24.75 General
Category: VILOXAZINE HYDROCHLORIDE
09/03/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $19.81 General
Category: Neuropsychiatry
08/27/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $18.36 General
Category: ANTI-ANXIETY
08/20/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $30.24 General
Category: Neuroscience
08/06/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $19.36 General
Category: NEUROSCIENCE
07/31/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $20.17 General
Category: Neurology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 60 340 $43,775 $24,487
2022 2 46 236 $32,425 $19,022
2021 2 38 195 $24,200 $12,228
2020 2 38 209 $23,500 $11,452
Total Patients
182
Total Services
980
Medicare Billing
$67,189
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 24 153 $22,950 $15,822 68.9%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 24 153 $19,125 $8,269 43.2%
90785 Psychiatric services complicated by communication factor Office 2023 12 34 $1,700 $395.54 23.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 23 117 $17,550 $12,346 70.3%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 23 119 $14,875 $6,677 44.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 19 88 $10,825 $6,144 56.8%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 19 107 $13,375 $6,084 45.5%
90833 Psychotherapy, 30 minutes Office 2020 19 104 $13,000 $5,833 44.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 19 105 $10,500 $5,619 53.5%

About Dr. Aura-Marie Pawley, M.D

Dr. Aura-Marie Pawley, M.D is a Neurology healthcare provider based in San Marino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639207400.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aura-Marie Pawley, M.D has received a total of $6,832 in payments from pharmaceutical and medical device companies, with $1,301 received in 2024. These payments were reported across 355 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,777).

As a Medicare-enrolled provider, Pawley has provided services to 182 Medicare beneficiaries, totaling 980 services with total Medicare billing of $67,189. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location San Marino, CA
  • Active Since 03/01/2007
  • Last Updated 11/26/2007
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1639207400

Products in Payments

  • REXULTI (Drug) $1,212
  • VRAYLAR (Drug) $825.44
  • LATUDA (Drug) $519.59
  • TRINTELLIX (Drug) $479.09
  • ABILIFY MAINTENA (Drug) $397.49
  • ARISTADA (Drug) $289.41
  • Trintellix (Drug) $277.08
  • Dyanavel XR (Drug) $206.33
  • NUEDEXTA (Drug) $184.02
  • AUSTEDO (Drug) $165.35
  • Aristada 441 mg (Drug) $162.32
  • INVEGA SUSTENNA (Drug) $157.32
  • Adzenys XR-ODT (Drug) $154.15
  • JORNAY PM (Drug) $139.59
  • BELSOMRA (Drug) $130.04
  • Auvelity (Drug) $126.81
  • INGREZZA (Drug) $124.54
  • CAPLYTA (Drug) $121.05
  • HETLIOZ (Drug) $118.20
  • Austedo XR (Drug) $110.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.